

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * eosinophil chemotaxis (GO:0048245) | 7.54094480 |
| 2 | * eosinophil migration (GO:0072677) | 6.48281619 |
| 3 | neutrophil activation involved in immune response (GO:0002283) | 6.43440473 |
| 4 | cellular response to zinc ion (GO:0071294) | 6.28998542 |
| 5 | phagocytosis, engulfment (GO:0006911) | 6.19544306 |
| 6 | regulation of mononuclear cell migration (GO:0071675) | 6.05529838 |
| 7 | regulation of macrophage chemotaxis (GO:0010758) | 5.74655830 |
| 8 | negative regulation of interleukin-12 production (GO:0032695) | 5.63406828 |
| 9 | negative regulation of leukocyte chemotaxis (GO:0002689) | 5.62628590 |
| 10 | positive regulation of monocyte chemotaxis (GO:0090026) | 5.43624728 |
| 11 | pinocytosis (GO:0006907) | 5.32384828 |
| 12 | cellular response to cadmium ion (GO:0071276) | 4.97128154 |
| 13 | cellular extravasation (GO:0045123) | 4.89716359 |
| 14 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 4.86780974 |
| 15 | microglial cell activation (GO:0001774) | 4.74398904 |
| 16 | regulation of monocyte chemotaxis (GO:0090025) | 4.73264957 |
| 17 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.68357117 |
| 18 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.45719235 |
| 19 | positive regulation of macrophage differentiation (GO:0045651) | 4.30025377 |
| 20 | immunoglobulin mediated immune response (GO:0016064) | 4.16391494 |
| 21 | macrophage activation (GO:0042116) | 4.12893031 |
| 22 | macrophage activation involved in immune response (GO:0002281) | 4.05463958 |
| 23 | * monocyte chemotaxis (GO:0002548) | 4.05417412 |
| 24 | positive regulation of osteoblast proliferation (GO:0033690) | 4.03843782 |
| 25 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.02326605 |
| 26 | glycosphingolipid catabolic process (GO:0046479) | 3.98438963 |
| 27 | membrane invagination (GO:0010324) | 3.95791040 |
| 28 | lymphocyte chemotaxis (GO:0048247) | 3.92790841 |
| 29 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 3.91664163 |
| 30 | positive regulation by symbiont of host defense response (GO:0052509) | 3.84263660 |
| 31 | modulation by symbiont of host defense response (GO:0052031) | 3.84263660 |
| 32 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.84263660 |
| 33 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.84263660 |
| 34 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.84263660 |
| 35 | modulation by symbiont of host immune response (GO:0052553) | 3.84263660 |
| 36 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.73946835 |
| 37 | regulation of vitamin metabolic process (GO:0030656) | 3.65473998 |
| 38 | response to peptidoglycan (GO:0032494) | 3.61791677 |
| 39 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.61602498 |
| 40 | glycolipid catabolic process (GO:0019377) | 3.56920560 |
| 41 | regulation of apoptotic cell clearance (GO:2000425) | 3.50699892 |
| 42 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.49845606 |
| 43 | positive regulation of p38MAPK cascade (GO:1900745) | 3.49742926 |
| 44 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.48929861 |
| 45 | macrophage chemotaxis (GO:0048246) | 3.48714089 |
| 46 | cyclooxygenase pathway (GO:0019371) | 3.48213818 |
| 47 | positive regulation of type 2 immune response (GO:0002830) | 3.47093926 |
| 48 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.43922583 |
| 49 | barbed-end actin filament capping (GO:0051016) | 3.43017645 |
| 50 | response to thyroid hormone (GO:0097066) | 3.41694379 |
| 51 | oligosaccharide catabolic process (GO:0009313) | 3.41619572 |
| 52 | negative regulation of mast cell activation (GO:0033004) | 3.40140310 |
| 53 | neutrophil migration (GO:1990266) | 3.40069190 |
| 54 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.39423746 |
| 55 | * regulation of lymphocyte migration (GO:2000401) | 3.37689764 |
| 56 | regulation of podosome assembly (GO:0071801) | 3.34586198 |
| 57 | regulation of hypersensitivity (GO:0002883) | 3.33983101 |
| 58 | negative regulation of interleukin-17 production (GO:0032700) | 3.33014919 |
| 59 | positive regulation of heat generation (GO:0031652) | 3.28519876 |
| 60 | response to muramyl dipeptide (GO:0032495) | 3.26437788 |
| 61 | lipoxygenase pathway (GO:0019372) | 3.26233439 |
| 62 | positive regulation of smooth muscle cell migration (GO:0014911) | 3.26162334 |
| 63 | positive regulation of phagocytosis (GO:0050766) | 3.25186047 |
| 64 | positive regulation of acute inflammatory response (GO:0002675) | 3.23860331 |
| 65 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.23303279 |
| 66 | regulation of cholesterol storage (GO:0010885) | 3.22147318 |
| 67 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.21348212 |
| 68 | cellular response to lipopolysaccharide (GO:0071222) | 3.21308900 |
| 69 | myeloid cell activation involved in immune response (GO:0002275) | 3.21039983 |
| 70 | negative regulation of granulocyte differentiation (GO:0030853) | 3.20730264 |
| 71 | extracellular fibril organization (GO:0043206) | 3.20655885 |
| 72 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.20601459 |
| 73 | neutrophil activation (GO:0042119) | 3.20557503 |
| 74 | respiratory burst (GO:0045730) | 3.19530758 |
| 75 | ceramide catabolic process (GO:0046514) | 3.19275873 |
| 76 | granulocyte activation (GO:0036230) | 3.19081372 |
| 77 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.18970615 |
| 78 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.17981875 |
| 79 | macrophage differentiation (GO:0030225) | 3.15850925 |
| 80 | cellular response to molecule of bacterial origin (GO:0071219) | 3.15375637 |
| 81 | positive regulation of mast cell activation (GO:0033005) | 3.13305076 |
| 82 | regulation of fever generation (GO:0031620) | 3.13258930 |
| 83 | regulation of vascular endothelial growth factor production (GO:0010574) | 3.11226080 |
| 84 | positive regulation of chemokine secretion (GO:0090197) | 3.10210841 |
| 85 | myeloid dendritic cell differentiation (GO:0043011) | 3.09775886 |
| 86 | positive regulation of macrophage cytokine production (GO:0060907) | 3.09107516 |
| 87 | * granulocyte chemotaxis (GO:0071621) | 3.08960868 |
| 88 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.08357996 |
| 89 | B cell mediated immunity (GO:0019724) | 3.08032020 |
| 90 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.06742384 |
| 91 | fibril organization (GO:0097435) | 3.06379334 |
| 92 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.05498658 |
| 93 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.04392343 |
| 94 | regulation of mast cell degranulation (GO:0043304) | 3.04333435 |
| 95 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.03946316 |
| 96 | sexual reproduction (GO:0019953) | 3.03254413 |
| 97 | positive regulation of calcium ion import (GO:0090280) | 3.03150003 |
| 98 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.02955370 |
| 99 | apoptotic cell clearance (GO:0043277) | 3.02356504 |
| 100 | * regulation of lymphocyte chemotaxis (GO:1901623) | 3.02052732 |
| 101 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.01349728 |
| 102 | regulation of macrophage differentiation (GO:0045649) | 2.99786206 |
| 103 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.99278889 |
| 104 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.99218938 |
| 105 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.99135926 |
| 106 | osteoclast differentiation (GO:0030316) | 2.99092782 |
| 107 | detection of molecule of bacterial origin (GO:0032490) | 2.98900463 |
| 108 | NIK/NF-kappaB signaling (GO:0038061) | 2.97968806 |
| 109 | intracellular pH reduction (GO:0051452) | 2.96744114 |
| 110 | decidualization (GO:0046697) | 2.96174056 |
| 111 | membrane lipid catabolic process (GO:0046466) | 2.95450134 |
| 112 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.95293179 |
| 113 | positive regulation of mast cell degranulation (GO:0043306) | 2.95293179 |
| 114 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.95257547 |
| 115 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.93466730 |
| 116 | * granulocyte migration (GO:0097530) | 2.93204524 |
| 117 | T-helper 1 type immune response (GO:0042088) | 2.92871931 |
| 118 | cellular response to ATP (GO:0071318) | 2.91350379 |
| 119 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.90859250 |
| 120 | detection of external biotic stimulus (GO:0098581) | 2.90162011 |
| 121 | cell adhesion mediated by integrin (GO:0033627) | 2.89850253 |
| 122 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.89391648 |
| 123 | response to host immune response (GO:0052572) | 2.89391648 |
| 124 | phagosome maturation (GO:0090382) | 2.88525167 |
| 125 | response to interferon-gamma (GO:0034341) | 2.86871060 |
| 126 | cellular response to interferon-gamma (GO:0071346) | 2.86344321 |
| 127 | regulation of granulocyte chemotaxis (GO:0071622) | 2.85072798 |
| 128 | negative regulation of leukocyte migration (GO:0002686) | 2.84933492 |
| 129 | glial cell migration (GO:0008347) | 2.84578574 |
| 130 | * positive regulation of leukocyte migration (GO:0002687) | 2.84414267 |
| 131 | regulation of antigen processing and presentation (GO:0002577) | 2.83799883 |
| 132 | sphingolipid catabolic process (GO:0030149) | 2.82143565 |
| 133 | regulation of myeloid cell apoptotic process (GO:0033032) | 2.82070940 |
| 134 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.81880469 |
| 135 | regulation of interferon-alpha production (GO:0032647) | 2.80793332 |
| 136 | dermatan sulfate biosynthetic process (GO:0030208) | 2.79903836 |
| 137 | regulation of T cell migration (GO:2000404) | 2.77450590 |
| 138 | positive regulation of interferon-alpha production (GO:0032727) | 2.77421798 |
| 139 | response to laminar fluid shear stress (GO:0034616) | 2.77342583 |
| 140 | positive regulation of antigen processing and presentation (GO:0002579) | 2.76956574 |
| 141 | negative regulation of chemotaxis (GO:0050922) | 2.76772068 |
| 142 | negative regulation of biomineral tissue development (GO:0070168) | 2.74392744 |
| 143 | * positive regulation of leukocyte chemotaxis (GO:0002690) | 2.73320758 |
| 144 | T cell migration (GO:0072678) | 2.72017992 |
| 145 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.70920327 |
| 146 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.70858705 |
| 147 | vagina development (GO:0060068) | 2.70826295 |
| 148 | regulation of phagocytosis (GO:0050764) | 2.69750892 |
| 149 | production of molecular mediator of immune response (GO:0002440) | 2.68878374 |
| 150 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.67515820 |
| 151 | substrate-dependent cell migration (GO:0006929) | 2.67198012 |
| 152 | * regulation of leukocyte chemotaxis (GO:0002688) | 2.66698414 |
| 153 | negative regulation of alcohol biosynthetic process (GO:1902931) | 2.62956698 |
| 154 | response to fluid shear stress (GO:0034405) | 2.62572867 |
| 155 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.62029793 |
| 156 | * regulation of leukocyte migration (GO:0002685) | 2.60113488 |
| 157 | neutrophil chemotaxis (GO:0030593) | 2.58967304 |
| 158 | positive regulation of astrocyte differentiation (GO:0048711) | 2.57200592 |
| 159 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.56029654 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.77922671 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.57616424 |
| 3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.84005710 |
| 4 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.73710441 |
| 5 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.70262136 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.37440591 |
| 7 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.32816167 |
| 8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.15793483 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.05253580 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.89778154 |
| 11 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.62668500 |
| 12 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.53328313 |
| 13 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.51690363 |
| 14 | GATA1_22025678_ChIP-Seq_K562_Human | 2.50593785 |
| 15 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.32436601 |
| 16 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.29637873 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.27648861 |
| 18 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.25837670 |
| 19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.21413144 |
| 20 | CJUN_26792858_Chip-Seq_BT549_Human | 2.05920244 |
| 21 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.97727801 |
| 22 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.94905114 |
| 23 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.87925466 |
| 24 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.86632768 |
| 25 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.86228287 |
| 26 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.83730316 |
| 27 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.80237487 |
| 28 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.80036949 |
| 29 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.76403611 |
| 30 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.71410632 |
| 31 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.71073997 |
| 32 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.68818925 |
| 33 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.68081579 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.63708599 |
| 35 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.63347239 |
| 36 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.62161538 |
| 37 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.60978686 |
| 38 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.59923838 |
| 39 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59907341 |
| 40 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.55470551 |
| 41 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52437945 |
| 42 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.51189487 |
| 43 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.49894319 |
| 44 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.49534500 |
| 45 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.48984239 |
| 46 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.48943400 |
| 47 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.48943400 |
| 48 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.48943400 |
| 49 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.47274120 |
| 50 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.44940212 |
| 51 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.44855352 |
| 52 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.40882494 |
| 53 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.40882494 |
| 54 | TP53_16413492_ChIP-PET_HCT116_Human | 1.39600396 |
| 55 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39172780 |
| 56 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.37667236 |
| 57 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.37587136 |
| 58 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.36346162 |
| 59 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.36159263 |
| 60 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.35411165 |
| 61 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32084881 |
| 62 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30857132 |
| 63 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.25066650 |
| 64 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.23301386 |
| 65 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.23240640 |
| 66 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.22701750 |
| 67 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.22405872 |
| 68 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22333504 |
| 69 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.21284369 |
| 70 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.20764261 |
| 71 | MAF_26560356_Chip-Seq_TH1_Human | 1.20447952 |
| 72 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.20415278 |
| 73 | MYB_26560356_Chip-Seq_TH2_Human | 1.19452070 |
| 74 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.18754093 |
| 75 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18283631 |
| 76 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17510639 |
| 77 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.17233106 |
| 78 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16585686 |
| 79 | SPI1_23127762_ChIP-Seq_K562_Human | 1.16537263 |
| 80 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.14916370 |
| 81 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.14088743 |
| 82 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.10858097 |
| 83 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.10742320 |
| 84 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.10079413 |
| 85 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.09856336 |
| 86 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.09855538 |
| 87 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.09595766 |
| 88 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.08775760 |
| 89 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.08189550 |
| 90 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.05249649 |
| 91 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.04813977 |
| 92 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03526028 |
| 93 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.02862790 |
| 94 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.02163913 |
| 95 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.02065383 |
| 96 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01557253 |
| 97 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.01312959 |
| 98 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.01200805 |
| 99 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.00304380 |
| 100 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97577984 |
| 101 | UTX_26944678_Chip-Seq_JUKART_Human | 0.97477433 |
| 102 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.97052622 |
| 103 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.96610310 |
| 104 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.96221217 |
| 105 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95313890 |
| 106 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94998519 |
| 107 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.94174886 |
| 108 | GATA3_26560356_Chip-Seq_TH2_Human | 0.92497101 |
| 109 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.92422531 |
| 110 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.90969442 |
| 111 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.90947218 |
| 112 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.89846212 |
| 113 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88937789 |
| 114 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.88759477 |
| 115 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.88577240 |
| 116 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.87196114 |
| 117 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.86480506 |
| 118 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.85174049 |
| 119 | MYB_26560356_Chip-Seq_TH1_Human | 0.84945730 |
| 120 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.84688299 |
| 121 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.83016733 |
| 122 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.82944264 |
| 123 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.81724792 |
| 124 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81652253 |
| 125 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.81254308 |
| 126 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.79524126 |
| 127 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.79524126 |
| 128 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.79499699 |
| 129 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.79365575 |
| 130 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.78930859 |
| 131 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.78235339 |
| 132 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.77926442 |
| 133 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77850896 |
| 134 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.77577349 |
| 135 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.76509401 |
| 136 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.76440831 |
| 137 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.76344262 |
| 138 | GATA2_19941826_ChIP-Seq_K562_Human | 0.75922784 |
| 139 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.75678673 |
| 140 | GATA1_19941826_ChIP-Seq_K562_Human | 0.75347977 |
| 141 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.74985570 |
| 142 | MAF_26560356_Chip-Seq_TH2_Human | 0.73701034 |
| 143 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.69307417 |
| 144 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.69212396 |
| 145 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.68197495 |
| 146 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.67672548 |
| 147 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.67370464 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 5.45337138 |
| 2 | MP0003279_aneurysm | 3.78086389 |
| 3 | MP0009840_abnormal_foam_cell | 3.65718795 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.56798744 |
| 5 | MP0003436_decreased_susceptibility_to | 3.47380435 |
| 6 | MP0005275_abnormal_skin_tensile | 3.25005985 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 3.19756861 |
| 8 | MP0005167_abnormal_blood-brain_barrier | 3.06455046 |
| 9 | MP0005503_abnormal_tendon_morphology | 3.05046582 |
| 10 | MP0000343_altered_response_to | 2.94882609 |
| 11 | MP0003303_peritoneal_inflammation | 2.91128309 |
| 12 | MP0002254_reproductive_system_inflammat | 2.91088277 |
| 13 | MP0005058_abnormal_lysosome_morphology | 2.86321759 |
| 14 | MP0009278_abnormal_bone_marrow | 2.77179035 |
| 15 | MP0002139_abnormal_hepatobiliary_system | 2.41355207 |
| 16 | MP0010368_abnormal_lymphatic_system | 2.40798046 |
| 17 | MP0001533_abnormal_skeleton_physiology | 2.40564279 |
| 18 | MP0002419_abnormal_innate_immunity | 2.29711164 |
| 19 | MP0009384_cardiac_valve_regurgitation | 2.27325212 |
| 20 | MP0003950_abnormal_plasma_membrane | 2.25735107 |
| 21 | MP0005000_abnormal_immune_tolerance | 2.23131605 |
| 22 | MP0002295_abnormal_pulmonary_circulatio | 2.20910425 |
| 23 | MP0003806_abnormal_nucleotide_metabolis | 2.16020786 |
| 24 | MP0001835_abnormal_antigen_presentation | 2.13997520 |
| 25 | MP0006054_spinal_hemorrhage | 2.13097672 |
| 26 | MP0003724_increased_susceptibility_to | 2.11778286 |
| 27 | MP0006082_CNS_inflammation | 2.06295777 |
| 28 | MP0003191_abnormal_cellular_cholesterol | 2.00371607 |
| 29 | MP0002837_dystrophic_cardiac_calcinosis | 1.90955246 |
| 30 | MP0005164_abnormal_response_to | 1.89036805 |
| 31 | MP0009785_altered_susceptibility_to | 1.85155547 |
| 32 | MP0003690_abnormal_glial_cell | 1.83888318 |
| 33 | MP0001958_emphysema | 1.82044067 |
| 34 | MP0005023_abnormal_wound_healing | 1.78656638 |
| 35 | MP0009764_decreased_sensitivity_to | 1.74492208 |
| 36 | MP0000604_amyloidosis | 1.72777411 |
| 37 | MP0005390_skeleton_phenotype | 1.72326878 |
| 38 | MP0010352_gastrointestinal_tract_polyps | 1.66887963 |
| 39 | MP0005171_absent_coat_pigmentation | 1.66021950 |
| 40 | MP0003195_calcinosis | 1.65904426 |
| 41 | MP0003075_altered_response_to | 1.65891466 |
| 42 | MP0000685_abnormal_immune_system | 1.65846142 |
| 43 | MP0001790_abnormal_immune_system | 1.63738392 |
| 44 | MP0005387_immune_system_phenotype | 1.63738392 |
| 45 | MP0002452_abnormal_antigen_presenting | 1.60628938 |
| 46 | MP0005397_hematopoietic_system_phenotyp | 1.60307080 |
| 47 | MP0001545_abnormal_hematopoietic_system | 1.60307080 |
| 48 | MP0002405_respiratory_system_inflammati | 1.58203594 |
| 49 | MP0005025_abnormal_response_to | 1.54072984 |
| 50 | MP0005310_abnormal_salivary_gland | 1.52653854 |
| 51 | MP0003172_abnormal_lysosome_physiology | 1.52208243 |
| 52 | MP0002998_abnormal_bone_remodeling | 1.50222380 |
| 53 | MP0004947_skin_inflammation | 1.49655862 |
| 54 | MP0002723_abnormal_immune_serum | 1.44263652 |
| 55 | MP0002933_joint_inflammation | 1.37746897 |
| 56 | MP0005464_abnormal_platelet_physiology | 1.36740436 |
| 57 | MP0003453_abnormal_keratinocyte_physiol | 1.35408105 |
| 58 | MP0003656_abnormal_erythrocyte_physiolo | 1.34757304 |
| 59 | MP0005623_abnormal_meninges_morphology | 1.34132682 |
| 60 | MP0001800_abnormal_humoral_immune | 1.31488997 |
| 61 | MP0008260_abnormal_autophagy | 1.29907122 |
| 62 | MP0001727_abnormal_embryo_implantation | 1.28536891 |
| 63 | MP0008004_abnormal_stomach_pH | 1.27153039 |
| 64 | MP0000767_abnormal_smooth_muscle | 1.21251451 |
| 65 | MP0005671_abnormal_response_to | 1.19506329 |
| 66 | MP0005257_abnormal_intraocular_pressure | 1.18871139 |
| 67 | MP0002420_abnormal_adaptive_immunity | 1.16963566 |
| 68 | MP0003828_pulmonary_edema | 1.16613409 |
| 69 | MP0005197_abnormal_uvea_morphology | 1.16058130 |
| 70 | MP0000569_abnormal_digit_pigmentation | 1.15159486 |
| 71 | MP0005451_abnormal_body_composition | 1.14582831 |
| 72 | MP0000750_abnormal_muscle_regeneration | 1.14573025 |
| 73 | MP0003329_amyloid_beta_deposits | 1.14258728 |
| 74 | MP0001819_abnormal_immune_cell | 1.13790953 |
| 75 | MP0001845_abnormal_inflammatory_respons | 1.12364605 |
| 76 | MP0003183_abnormal_peptide_metabolism | 1.10417238 |
| 77 | MP0003448_altered_tumor_morphology | 1.10078206 |
| 78 | MP0005508_abnormal_skeleton_morphology | 1.09655700 |
| 79 | MP0001542_abnormal_bone_strength | 1.08039113 |
| 80 | MP0000371_diluted_coat_color | 1.07590207 |
| 81 | MP0002060_abnormal_skin_morphology | 1.06175145 |
| 82 | MP0000249_abnormal_blood_vessel | 1.06151806 |
| 83 | MP0004510_myositis | 1.05104163 |
| 84 | MP0001851_eye_inflammation | 1.04297783 |
| 85 | MP0005595_abnormal_vascular_smooth | 1.02648382 |
| 86 | MP0003091_abnormal_cell_migration | 1.01419703 |
| 87 | MP0002277_abnormal_respiratory_mucosa | 1.01124336 |
| 88 | MP0003795_abnormal_bone_structure | 1.00901449 |
| 89 | MP0005166_decreased_susceptibility_to | 0.98588069 |
| 90 | MP0008469_abnormal_protein_level | 0.98163585 |
| 91 | MP0009765_abnormal_xenobiotic_induced | 0.98096725 |
| 92 | MP0005076_abnormal_cell_differentiation | 0.97752904 |
| 93 | MP0000920_abnormal_myelination | 0.95351919 |
| 94 | MP0004883_abnormal_blood_vessel | 0.93566858 |
| 95 | MP0002877_abnormal_melanocyte_morpholog | 0.93262561 |
| 96 | MP0001879_abnormal_lymphatic_vessel | 0.90057174 |
| 97 | MP0000858_altered_metastatic_potential | 0.88816934 |
| 98 | MP0001243_abnormal_dermal_layer | 0.86548277 |
| 99 | MP0001915_intracranial_hemorrhage | 0.85076553 |
| 100 | MP0004233_abnormal_muscle_weight | 0.83728718 |
| 101 | MP0002332_abnormal_exercise_endurance | 0.82098146 |
| 102 | MP0005165_increased_susceptibility_to | 0.79122390 |
| 103 | MP0010155_abnormal_intestine_physiology | 0.77930400 |
| 104 | MP0005388_respiratory_system_phenotype | 0.77925335 |
| 105 | MP0002133_abnormal_respiratory_system | 0.77925335 |
| 106 | MP0000516_abnormal_urinary_system | 0.77361775 |
| 107 | MP0005367_renal/urinary_system_phenotyp | 0.77361775 |
| 108 | * MP0002429_abnormal_blood_cell | 0.76012234 |
| 109 | MP0005365_abnormal_bile_salt | 0.75811687 |
| 110 | MP0002398_abnormal_bone_marrow | 0.70535814 |
| 111 | MP0001853_heart_inflammation | 0.69095140 |
| 112 | MP0010307_abnormal_tumor_latency | 0.68536135 |
| 113 | MP0000465_gastrointestinal_hemorrhage | 0.66045926 |
| 114 | MP0000015_abnormal_ear_pigmentation | 0.65815027 |
| 115 | MP0004272_abnormal_basement_membrane | 0.65501100 |
| 116 | MP0005647_abnormal_sex_gland | 0.65399903 |
| 117 | MP0000689_abnormal_spleen_morphology | 0.64200347 |
| 118 | MP0009763_increased_sensitivity_to | 0.61828904 |
| 119 | MP0002090_abnormal_vision | 0.61433371 |
| 120 | MP0003634_abnormal_glial_cell | 0.60329228 |
| 121 | MP0009333_abnormal_splenocyte_physiolog | 0.60321373 |
| 122 | MP0005319_abnormal_enzyme/_coenzyme | 0.59144545 |
| 123 | MP0003300_gastrointestinal_ulcer | 0.58139158 |
| 124 | MP0008874_decreased_physiological_sensi | 0.58082594 |
| 125 | MP0002896_abnormal_bone_mineralization | 0.57845989 |
| 126 | MP0001663_abnormal_digestive_system | 0.57668581 |
| 127 | MP0000609_abnormal_liver_physiology | 0.57208539 |
| 128 | MP0003633_abnormal_nervous_system | 0.56808444 |
| 129 | * MP0000716_abnormal_immune_system | 0.56678971 |
| 130 | MP0001175_abnormal_lung_morphology | 0.56343768 |
| 131 | MP0001849_ear_inflammation | 0.55122273 |
| 132 | MP0002396_abnormal_hematopoietic_system | 0.54953156 |
| 133 | MP0003186_abnormal_redox_activity | 0.53868652 |
| 134 | MP0002136_abnormal_kidney_physiology | 0.53282903 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 7.35114684 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 7.35114684 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 7.35114684 |
| 4 | Systemic lupus erythematosus (HP:0002725) | 5.80583442 |
| 5 | Spontaneous hematomas (HP:0007420) | 5.39831095 |
| 6 | Protrusio acetabuli (HP:0003179) | 5.09316416 |
| 7 | Axonal loss (HP:0003447) | 4.99672044 |
| 8 | Recurrent abscess formation (HP:0002722) | 4.52236987 |
| 9 | Vertebral compression fractures (HP:0002953) | 4.49277067 |
| 10 | Glomerulonephritis (HP:0000099) | 4.29572684 |
| 11 | Premature rupture of membranes (HP:0001788) | 4.22552137 |
| 12 | Disinhibition (HP:0000734) | 4.05202361 |
| 13 | Loss of speech (HP:0002371) | 3.95138282 |
| 14 | Vascular tortuosity (HP:0004948) | 3.82132176 |
| 15 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.81384544 |
| 16 | Vacuolated lymphocytes (HP:0001922) | 3.81241094 |
| 17 | Arterial tortuosity (HP:0005116) | 3.78467671 |
| 18 | Prostate neoplasm (HP:0100787) | 3.77518237 |
| 19 | Osteolytic defects of the hand bones (HP:0009699) | 3.72512666 |
| 20 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.72512666 |
| 21 | Abnormality of complement system (HP:0005339) | 3.68038139 |
| 22 | Metaphyseal irregularity (HP:0003025) | 3.58985000 |
| 23 | Mutism (HP:0002300) | 3.54305984 |
| 24 | Complement deficiency (HP:0004431) | 3.52116655 |
| 25 | Atrophic scars (HP:0001075) | 3.41498385 |
| 26 | Myocardial infarction (HP:0001658) | 3.40820284 |
| 27 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.25518064 |
| 28 | Fragile skin (HP:0001030) | 3.23523770 |
| 29 | Soft skin (HP:0000977) | 3.22243389 |
| 30 | Chronic obstructive pulmonary disease (HP:0006510) | 3.22023716 |
| 31 | Obstructive lung disease (HP:0006536) | 3.22023716 |
| 32 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.20345600 |
| 33 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.20345600 |
| 34 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.20345600 |
| 35 | Aortic dissection (HP:0002647) | 3.16870550 |
| 36 | Agnosia (HP:0010524) | 3.16464011 |
| 37 | Stomatitis (HP:0010280) | 3.15120327 |
| 38 | Premature loss of primary teeth (HP:0006323) | 3.13881910 |
| 39 | Aortic aneurysm (HP:0004942) | 3.11605416 |
| 40 | Increased cerebral lipofuscin (HP:0011813) | 3.10296399 |
| 41 | Recurrent bacterial skin infections (HP:0005406) | 3.08912760 |
| 42 | Dysostosis multiplex (HP:0000943) | 3.05340875 |
| 43 | Hematochezia (HP:0002573) | 3.04893062 |
| 44 | Autoimmune thrombocytopenia (HP:0001973) | 3.04825054 |
| 45 | Increased serum ferritin (HP:0003281) | 3.03952164 |
| 46 | Peritonitis (HP:0002586) | 3.02138013 |
| 47 | Eczematoid dermatitis (HP:0000976) | 2.96516476 |
| 48 | Wormian bones (HP:0002645) | 2.91853571 |
| 49 | Upper motor neuron abnormality (HP:0002127) | 2.76869432 |
| 50 | Dilatation of the ascending aorta (HP:0005111) | 2.75673523 |
| 51 | Cerebral aneurysm (HP:0004944) | 2.72413874 |
| 52 | Recurrent fungal infections (HP:0002841) | 2.71542364 |
| 53 | Malnutrition (HP:0004395) | 2.70081007 |
| 54 | Basal ganglia calcification (HP:0002135) | 2.69816589 |
| 55 | Pathologic fracture (HP:0002756) | 2.68886626 |
| 56 | Hemoptysis (HP:0002105) | 2.68328488 |
| 57 | Neurofibrillary tangles (HP:0002185) | 2.68281961 |
| 58 | Recurrent cutaneous fungal infections (HP:0011370) | 2.66447208 |
| 59 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.66447208 |
| 60 | Peripheral demyelination (HP:0011096) | 2.65732690 |
| 61 | Bone pain (HP:0002653) | 2.60077311 |
| 62 | Diminished motivation (HP:0000745) | 2.59170900 |
| 63 | Joint hemorrhage (HP:0005261) | 2.56828510 |
| 64 | Retinal atrophy (HP:0001105) | 2.55087392 |
| 65 | Nephritis (HP:0000123) | 2.53182660 |
| 66 | Thick nail (HP:0001805) | 2.52589003 |
| 67 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.51993721 |
| 68 | Progressive visual loss (HP:0000529) | 2.50144010 |
| 69 | Bladder diverticulum (HP:0000015) | 2.49568081 |
| 70 | Apathy (HP:0000741) | 2.49043330 |
| 71 | Blue sclerae (HP:0000592) | 2.48469999 |
| 72 | Abnormality of macrophages (HP:0004311) | 2.46583271 |
| 73 | Neuronal loss in central nervous system (HP:0002529) | 2.46477600 |
| 74 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.45753082 |
| 75 | Myositis (HP:0100614) | 2.45540951 |
| 76 | Nausea (HP:0002018) | 2.44410192 |
| 77 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.42686951 |
| 78 | Petechiae (HP:0000967) | 2.42396805 |
| 79 | Abnormality of iron homeostasis (HP:0011031) | 2.34891678 |
| 80 | Abnormality of the common coagulation pathway (HP:0010990) | 2.34305288 |
| 81 | Pulmonary infiltrates (HP:0002113) | 2.33150095 |
| 82 | Conjunctival telangiectasia (HP:0000524) | 2.28576180 |
| 83 | Albinism (HP:0001022) | 2.27961895 |
| 84 | Nuclear cataract (HP:0100018) | 2.27260673 |
| 85 | Urticaria (HP:0001025) | 2.27228527 |
| 86 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.26205072 |
| 87 | Orchitis (HP:0100796) | 2.24167802 |
| 88 | Pustule (HP:0200039) | 2.22791793 |
| 89 | Facial diplegia (HP:0001349) | 2.22637054 |
| 90 | Mitral stenosis (HP:0001718) | 2.18102298 |
| 91 | Supranuclear gaze palsy (HP:0000605) | 2.14242982 |
| 92 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.14227733 |
| 93 | Alopecia of scalp (HP:0002293) | 2.14051821 |
| 94 | Biconcave vertebral bodies (HP:0004586) | 2.13938909 |
| 95 | Broad ribs (HP:0000885) | 2.09982366 |
| 96 | Cheilitis (HP:0100825) | 2.08785232 |
| 97 | Tetraparesis (HP:0002273) | 2.07043113 |
| 98 | Purpura (HP:0000979) | 2.06642745 |
| 99 | Recurrent viral infections (HP:0004429) | 2.05132375 |
| 100 | Mitral valve prolapse (HP:0001634) | 2.03946205 |
| 101 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.02864972 |
| 102 | Spondylolisthesis (HP:0003302) | 2.02224607 |
| 103 | Hypoalphalipoproteinemia (HP:0003233) | 1.99552780 |
| 104 | Abnormality of the periventricular white matter (HP:0002518) | 1.97348458 |
| 105 | Esophageal neoplasm (HP:0100751) | 1.96847209 |
| 106 | Neoplasm of head and neck (HP:0012288) | 1.96847209 |
| 107 | Recurrent skin infections (HP:0001581) | 1.96599159 |
| 108 | Vasculitis (HP:0002633) | 1.95730763 |
| 109 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 1.94831311 |
| 110 | Bruising susceptibility (HP:0000978) | 1.94736630 |
| 111 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.94634987 |
| 112 | Inappropriate behavior (HP:0000719) | 1.94573610 |
| 113 | Progressive neurologic deterioration (HP:0002344) | 1.94268177 |
| 114 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.92698018 |
| 115 | Dementia (HP:0000726) | 1.92626984 |
| 116 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.90931638 |
| 117 | Thin bony cortex (HP:0002753) | 1.88423415 |
| 118 | Cerebral inclusion bodies (HP:0100314) | 1.87946808 |
| 119 | Meningitis (HP:0001287) | 1.87142399 |
| 120 | Hepatosplenomegaly (HP:0001433) | 1.86660460 |
| 121 | Protuberant abdomen (HP:0001538) | 1.86302732 |
| 122 | Short hallux (HP:0010109) | 1.85972199 |
| 123 | Prolonged neonatal jaundice (HP:0006579) | 1.85851662 |
| 124 | Gingivitis (HP:0000230) | 1.85258040 |
| 125 | Colitis (HP:0002583) | 1.85026394 |
| 126 | Flat occiput (HP:0005469) | 1.84038743 |
| 127 | Polyneuropathy (HP:0001271) | 1.82124427 |
| 128 | Genu recurvatum (HP:0002816) | 1.81228452 |
| 129 | Personality changes (HP:0000751) | 1.80828441 |
| 130 | Xanthomatosis (HP:0000991) | 1.78879031 |
| 131 | Keratoconjunctivitis sicca (HP:0001097) | 1.77096360 |
| 132 | Bone cyst (HP:0012062) | 1.76693018 |
| 133 | Hyperextensible skin (HP:0000974) | 1.76414728 |
| 134 | Mucopolysacchariduria (HP:0008155) | 1.74603448 |
| 135 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.74603448 |
| 136 | Pulmonary artery stenosis (HP:0004415) | 1.74589823 |
| 137 | Craniofacial hyperostosis (HP:0004493) | 1.74445399 |
| 138 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 1.72569800 |
| 139 | Abnormality of the frontal sinuses (HP:0002687) | 1.71441571 |
| 140 | Corneal dystrophy (HP:0001131) | 1.71229311 |
| 141 | Mucosal telangiectasiae (HP:0100579) | 1.70876792 |
| 142 | Retrobulbar optic neuritis (HP:0100654) | 1.69188053 |
| 143 | Optic neuritis (HP:0100653) | 1.69188053 |
| 144 | Spinal rigidity (HP:0003306) | 1.68928871 |
| 145 | Amyloidosis (HP:0011034) | 1.68046302 |
| 146 | Vaginal fistula (HP:0004320) | 1.65690833 |
| 147 | Osteomyelitis (HP:0002754) | 1.64706817 |
| 148 | Mediastinal lymphadenopathy (HP:0100721) | 1.64382043 |
| 149 | Abnormality of the pericardium (HP:0001697) | 1.63123320 |
| 150 | Anhidrosis (HP:0000970) | 1.62708068 |
| 151 | Joint stiffness (HP:0001387) | 1.61938123 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 5.29917992 |
| 2 | MAP3K10 | 4.78984254 |
| 3 | TGFBR2 | 4.64593674 |
| 4 | MAP3K14 | 3.45742178 |
| 5 | MOS | 3.39303184 |
| 6 | GRK7 | 3.00673390 |
| 7 | EPHB1 | 2.52135926 |
| 8 | FGR | 2.07296178 |
| 9 | PIM2 | 2.06592098 |
| 10 | SCYL2 | 2.01910397 |
| 11 | TBK1 | 1.98176222 |
| 12 | EIF2AK2 | 1.96729547 |
| 13 | CAMKK2 | 1.92563820 |
| 14 | IKBKB | 1.87891675 |
| 15 | STK24 | 1.84455135 |
| 16 | STK10 | 1.80654406 |
| 17 | CAMK1D | 1.74373245 |
| 18 | FRK | 1.73914540 |
| 19 | MKNK1 | 1.68082648 |
| 20 | MAP2K2 | 1.67096172 |
| 21 | IRAK4 | 1.66546456 |
| 22 | ERBB3 | 1.65848788 |
| 23 | TAOK2 | 1.63868485 |
| 24 | MAPKAPK5 | 1.58310586 |
| 25 | MAP3K3 | 1.52566212 |
| 26 | ERN1 | 1.51783028 |
| 27 | TYK2 | 1.50012404 |
| 28 | MAP3K13 | 1.47733913 |
| 29 | IKBKE | 1.44370365 |
| 30 | GRK5 | 1.43238448 |
| 31 | KIT | 1.42433327 |
| 32 | PAK4 | 1.21768052 |
| 33 | TESK1 | 1.18572917 |
| 34 | NEK9 | 1.18401034 |
| 35 | IRAK3 | 1.18195176 |
| 36 | ACVR1B | 1.17429211 |
| 37 | CSK | 1.15842364 |
| 38 | CHUK | 1.13241792 |
| 39 | FES | 1.12597187 |
| 40 | TRPM7 | 1.11589701 |
| 41 | JAK3 | 1.11042537 |
| 42 | PIK3CG | 1.08429337 |
| 43 | CAMK1G | 1.08036098 |
| 44 | PRPF4B | 1.07728201 |
| 45 | BMPR2 | 1.07273338 |
| 46 | CDC42BPA | 1.06346992 |
| 47 | BMPR1B | 1.05697496 |
| 48 | ADRBK2 | 1.04110061 |
| 49 | CLK1 | 1.02095121 |
| 50 | TXK | 1.01978947 |
| 51 | PAK2 | 0.98939611 |
| 52 | LATS2 | 0.97534573 |
| 53 | MAP3K11 | 0.96278635 |
| 54 | TAOK1 | 0.96231544 |
| 55 | PTK2B | 0.94967496 |
| 56 | LYN | 0.90634274 |
| 57 | NTRK1 | 0.90043774 |
| 58 | NLK | 0.89762446 |
| 59 | DDR2 | 0.88606945 |
| 60 | MAPK12 | 0.85796687 |
| 61 | LCK | 0.84449876 |
| 62 | PRKD1 | 0.82324323 |
| 63 | MKNK2 | 0.81812813 |
| 64 | NME2 | 0.81753460 |
| 65 | ZAK | 0.80581414 |
| 66 | CDK6 | 0.80045157 |
| 67 | ABL2 | 0.78962851 |
| 68 | TESK2 | 0.76563651 |
| 69 | PIM1 | 0.76188699 |
| 70 | EPHA3 | 0.74447047 |
| 71 | ARAF | 0.74303119 |
| 72 | TTN | 0.71687013 |
| 73 | TAOK3 | 0.70820669 |
| 74 | EPHB2 | 0.70358278 |
| 75 | RPS6KA4 | 0.70031788 |
| 76 | KSR1 | 0.69932590 |
| 77 | MAP2K1 | 0.67700825 |
| 78 | ABL1 | 0.67496835 |
| 79 | INSR | 0.65661864 |
| 80 | ZAP70 | 0.65641495 |
| 81 | HCK | 0.64417726 |
| 82 | MAP3K1 | 0.62873691 |
| 83 | JAK1 | 0.61954775 |
| 84 | PTK2 | 0.61576905 |
| 85 | BMX | 0.60738282 |
| 86 | EGFR | 0.58791115 |
| 87 | PKN1 | 0.58178462 |
| 88 | SYK | 0.55983154 |
| 89 | PRKCD | 0.55594167 |
| 90 | MAP4K1 | 0.55220717 |
| 91 | RPS6KC1 | 0.55190293 |
| 92 | RPS6KL1 | 0.55190293 |
| 93 | MARK3 | 0.51580434 |
| 94 | GSK3A | 0.50787112 |
| 95 | PRKG2 | 0.50027820 |
| 96 | KSR2 | 0.49579166 |
| 97 | MAPKAPK2 | 0.49423783 |
| 98 | DAPK2 | 0.48191220 |
| 99 | RIPK4 | 0.47451548 |
| 100 | RPS6KA2 | 0.47294296 |
| 101 | MAPK4 | 0.47052850 |
| 102 | STK38L | 0.46824034 |
| 103 | IGF1R | 0.46722736 |
| 104 | PAK3 | 0.45747299 |
| 105 | TYRO3 | 0.45354514 |
| 106 | PDPK1 | 0.45285002 |
| 107 | RPS6KA6 | 0.45260993 |
| 108 | IRAK2 | 0.43478737 |
| 109 | PAK6 | 0.42877716 |
| 110 | DMPK | 0.42631776 |
| 111 | ADRBK1 | 0.41184683 |
| 112 | TEC | 0.40823519 |
| 113 | MAP2K3 | 0.40397589 |
| 114 | LIMK1 | 0.39687850 |
| 115 | TGFBR1 | 0.39102625 |
| 116 | MAP3K6 | 0.37878125 |
| 117 | PAK1 | 0.37355765 |
| 118 | PDK1 | 0.37275557 |
| 119 | MAP2K6 | 0.36972265 |
| 120 | RPS6KA5 | 0.36875504 |
| 121 | BTK | 0.36206279 |
| 122 | FYN | 0.35405428 |
| 123 | MAP3K5 | 0.34914764 |
| 124 | MELK | 0.34528271 |
| 125 | JAK2 | 0.34505898 |
| 126 | PDGFRB | 0.34300066 |
| 127 | CSF1R | 0.34170346 |
| 128 | MATK | 0.34127818 |
| 129 | PBK | 0.32942143 |
| 130 | DAPK3 | 0.32625026 |
| 131 | CAMKK1 | 0.30567547 |
| 132 | RIPK1 | 0.30508981 |
| 133 | MAPKAPK3 | 0.30480913 |
| 134 | ITK | 0.29794869 |
| 135 | MAP3K8 | 0.29611208 |
| 136 | CAMK4 | 0.29489763 |
| 137 | STK3 | 0.29465656 |
| 138 | PDGFRA | 0.29270272 |
| 139 | PDK2 | 0.29268038 |
| 140 | MAP3K2 | 0.27313298 |
| 141 | IRAK1 | 0.24443874 |
| 142 | PKN2 | 0.21696888 |
| 143 | MAPK11 | 0.20535003 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.40836358 |
| 2 | Legionellosis_Homo sapiens_hsa05134 | 3.02502306 |
| 3 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.94637766 |
| 4 | Malaria_Homo sapiens_hsa05144 | 2.91135651 |
| 5 | Lysosome_Homo sapiens_hsa04142 | 2.64959298 |
| 6 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.34793548 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.28994761 |
| 8 | Salmonella infection_Homo sapiens_hsa05132 | 2.19621056 |
| 9 | Phagosome_Homo sapiens_hsa04145 | 2.15499472 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.15221266 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.12304095 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.09859105 |
| 13 | Pertussis_Homo sapiens_hsa05133 | 2.05539892 |
| 14 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.02837963 |
| 15 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.99582296 |
| 16 | Tuberculosis_Homo sapiens_hsa05152 | 1.95616560 |
| 17 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.81875064 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.81433739 |
| 19 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.81271640 |
| 20 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.75004893 |
| 21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.74085486 |
| 22 | Other glycan degradation_Homo sapiens_hsa00511 | 1.54555214 |
| 23 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.52303787 |
| 24 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.51960640 |
| 25 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.45020953 |
| 26 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.43561080 |
| 27 | Shigellosis_Homo sapiens_hsa05131 | 1.39270719 |
| 28 | Allograft rejection_Homo sapiens_hsa05330 | 1.39244345 |
| 29 | Apoptosis_Homo sapiens_hsa04210 | 1.36886829 |
| 30 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.35527988 |
| 31 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.35001923 |
| 32 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.34989613 |
| 33 | Mineral absorption_Homo sapiens_hsa04978 | 1.31868907 |
| 34 | Viral myocarditis_Homo sapiens_hsa05416 | 1.31823675 |
| 35 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.31445341 |
| 36 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.26231546 |
| 37 | Prion diseases_Homo sapiens_hsa05020 | 1.23137455 |
| 38 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.22226169 |
| 39 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.22192381 |
| 40 | Asthma_Homo sapiens_hsa05310 | 1.20342796 |
| 41 | Bladder cancer_Homo sapiens_hsa05219 | 1.16862082 |
| 42 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.14369948 |
| 43 | Amoebiasis_Homo sapiens_hsa05146 | 1.12555135 |
| 44 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.10279223 |
| 45 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.98242234 |
| 46 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.97782113 |
| 47 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.91648500 |
| 48 | Influenza A_Homo sapiens_hsa05164 | 0.91037915 |
| 49 | Measles_Homo sapiens_hsa05162 | 0.90961477 |
| 50 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.87456232 |
| 51 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.86881949 |
| 52 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.85558837 |
| 53 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.81994024 |
| 54 | Focal adhesion_Homo sapiens_hsa04510 | 0.81614260 |
| 55 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.75415794 |
| 56 | Hepatitis B_Homo sapiens_hsa05161 | 0.73746026 |
| 57 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.73339745 |
| 58 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.71200491 |
| 59 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.69597621 |
| 60 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.68839881 |
| 61 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.67470190 |
| 62 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.64130451 |
| 63 | Platelet activation_Homo sapiens_hsa04611 | 0.63807372 |
| 64 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.63753695 |
| 65 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.63368032 |
| 66 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.63264417 |
| 67 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.62766660 |
| 68 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.62425517 |
| 69 | Galactose metabolism_Homo sapiens_hsa00052 | 0.61641725 |
| 70 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.61445734 |
| 71 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.61261424 |
| 72 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.60930350 |
| 73 | Endocytosis_Homo sapiens_hsa04144 | 0.57662142 |
| 74 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.56292074 |
| 75 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56148967 |
| 76 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.55153589 |
| 77 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.52046767 |
| 78 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.51664272 |
| 79 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.50808892 |
| 80 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.50562764 |
| 81 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.50515746 |
| 82 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.49467178 |
| 83 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.48699534 |
| 84 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.48216732 |
| 85 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.47052352 |
| 86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46954442 |
| 87 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.45899542 |
| 88 | Melanoma_Homo sapiens_hsa05218 | 0.45627769 |
| 89 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.44061812 |
| 90 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.43566282 |
| 91 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.42541183 |
| 92 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.40534785 |
| 93 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.38809839 |
| 94 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.38045547 |
| 95 | Renin secretion_Homo sapiens_hsa04924 | 0.36770642 |
| 96 | Adherens junction_Homo sapiens_hsa04520 | 0.36426502 |
| 97 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.36306281 |
| 98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36149227 |
| 99 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.33866384 |
| 100 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.30914604 |
| 101 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.30226470 |
| 102 | Hepatitis C_Homo sapiens_hsa05160 | 0.30110927 |
| 103 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.30047120 |
| 104 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.29150214 |
| 105 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.29109418 |
| 106 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.28184232 |
| 107 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.28065297 |
| 108 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.27836880 |
| 109 | Pathways in cancer_Homo sapiens_hsa05200 | 0.25856593 |
| 110 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.25552452 |
| 111 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.22202764 |
| 112 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.21695270 |
| 113 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.21365543 |
| 114 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.21315148 |
| 115 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.21112903 |
| 116 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.20731684 |
| 117 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.16746855 |
| 118 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.16566524 |
| 119 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.15116398 |
| 120 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.12664107 |
| 121 | HTLV-I infection_Homo sapiens_hsa05166 | 0.12347429 |
| 122 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.11591473 |
| 123 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.06874667 |
| 124 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.05759223 |
| 125 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.03021514 |

